local
FDA approves Moderna's mRNA seasonal flu vaccine
Summary by The Piney Point Editorial Desk KTRK , as published by ABC13 Houston (KTRK)
· August 6, 2026
· 1 min read
Photo: ABC13 Houston (KTRK) · view original
Story provenance No corrections
Summary created by The Piney Point Editorial Desk — automated, rule-governed Byline on source page KTRK, as published by ABC13 Houston (KTRK) Original story Read at the source Source published Aug 6, 2026 Indexed here Aug 6, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway Further information about mFLUSIVA can be found through ABC13 Houston, which reported on the FDA approval and the vaccine's expected availability for the 2026-2027 season.
In a development related to public health, the FDA has given approval to Moderna's mRNA seasonal flu vaccine. This vaccine is known as mFLUSIVA. Details about the vaccine's availability are limited, but it is expected to be an option for certain individuals.
Specifically, people 50 and older may have access to mFLUSIVA for the upcoming respiratory illness season. Further information about mFLUSIVA can be found through ABC13 Houston, which reported on the FDA approval and the vaccine's expected availability for the 2026-2027 season.
Why this matters
Local news anchors readers in their community — the people, places, and decisions that shape day-to-day life. The Piney Point covers these stories because national outlets often won't.
About this story
As published by ABC13 Houston (KTRK) . The Piney Point surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit ABC13 Houston (KTRK) . Have a tip or correction? Contact our newsroom .
Category: local Published: August 6, 2026 Source: ABC13 Houston (KTRK) Reading time: 1 min
Frequently asked about this story
What is this story about? In a development related to public health, the FDA has given approval to Moderna's mRNA seasonal flu vaccine. This vaccine is known as mFLUSIVA. Details about the vaccine's availability are limited…
When was this published? This article was first published on August 6, 2026 by ABC13 Houston (KTRK) and curated for The Piney Point readers.
Who reported this story? This story was reported by KTRK at ABC13 Houston (KTRK). To learn more about how The Piney Point selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Piney Point, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter
